发明名称 ESTERS OF (+)-ALPHA-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL AND THEIR USE AS PRODRUGS OF THE 5HT2A RECEPTOR ANTAGONIST MDL 110,907
摘要 <p>Esters of (2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol (MDL 100907) (I), are new. Esters of (+)-alpha-(2,3-dimethoxy- phenyl)-1-[2(4-fluorophenyl)ethyl]-4-piperidine methanol of formula (I) and their stereoisomers and salts are new. [Image] R : 4-20C alkyl. ACTIVITY : Neuroleptic; Antimanic; Antidepressant; Tranquilizer; Antiaddictive; Cardiant; Antianginal; Thrombolytic; Eating-Disorders-Gen.; Vasotropic; Antiarrhythmic; Sedative. (+)-alpha-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl(ethyl]-4- piperidine methanol decanoate (120 mg/kg equivalent to MDL-100907) was administered to (+/-)-DOI HCl injected male Sprague-Dawley rats. (+/-)-DOI HCl induces several quantifiable behaviours in rats. Significantly antagonized DOI-induced behavior in the rats was observed for a full 28 days. The effect was no longer significant at day 40. MECHANISM OF ACTION : Antiserotonin-2A.</p>
申请公布号 HU0200517(A2) 申请公布日期 2002.06.29
申请号 HU20020000517 申请日期 1998.10.14
申请人 AVENTIS PHARMACEUTICALS INC. 发明人 CARR ALBERT A.;VAN HIJFTE LUC E.;JR. KOSLEY RAYMOND W.
分类号 C07D211/48;A61K;A61K31/445;A61P7/02;A61P9/06;A61P9/10;A61P25/00;A61P25/18;A61P25/22;A61P25/24;A61P25/30;C07D;C07D211/22;(IPC1-7):C07D211/22 主分类号 C07D211/48
代理机构 代理人
主权项
地址